Methyl iodide → 5-Chloro-1-methylpyrazin-2(1H)-one
反応式
[Cl:1][C:2]1[N:3]=[CH:4][C:5]([OH:8])=[N:6][CH:7]=1.[C:9]([O-])([O-])=O.[K+].[K+].CI>CN(C=O)C>[Cl:1][C:2]1[N:3]=[CH:4][C:5](=[O:8])[N:6]([CH3:9])[CH:7]=1参加物
5
実験手順
To a solution of 5-chloro-pyrazin-2-ol (100 mg, 0.76 mmol) in DMF (3 mL) was added K2CO3 (211 mg, 1.53 mmol) and CH3I (0.25 ml, 4 mmol) at room temperature. The mixture was stirred overnight, quenched by H2O, and extracted with EtOAc. The organic phase was concentrated to give the crude product, which was purified by TLC to give 5-chloro-1-methyl-1H-pyrazin-2-one (70 mg, 64%). 1H NMR (CD3OD): δ3.52 (s, 3H), 7.78 (s, 1H), 7.87 (s, 1H).
後処理
- customquenched by H2O
- extractionextracted with EtOAc
- concentrationThe organic phase was concentrated
- customto give the crude product, which
- customwas purified by TLC
出典と根拠
- ORDレコード
- ord-6c705502f0c04bddb05a3a25fe0af626
- 出典データセット
- uspto-grants-2013_11
- 特許番号
- US08592410B2
反応ノート
読み込み中…